一名患有胰岛细胞调节异常综合征的早产儿对生长抑素类似物的耐受性
Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.
作者信息
Hawdon J M, Ward Platt M P, Lamb W H, Aynsley-Green A
机构信息
Department of Child Health, Princess Mary Hospital, Newcastle upon Tyne.
出版信息
Arch Dis Child. 1991 Mar;66(3):341-3. doi: 10.1136/adc.66.3.341.
Abstract
An infant of 31 weeks' gestation presented with refractory neonatal hypoglycaemia secondary to islet cell dysregulation. Treatment was started with somatostatin analogue and his glycaemic control improved initially. Tolerance developed, however, in that the dose required to maintain control increased by a factor of 40. The infant subsequently underwent pancreatectomy. It is safe to use somatostatin analogue in a preterm infant, but tolerance to the drug rapidly develops.
摘要
一名孕31周的婴儿因胰岛细胞调节异常出现难治性新生儿低血糖。开始使用生长抑素类似物治疗，其血糖控制最初有所改善。然而，出现了耐受性，即维持控制所需的剂量增加了40倍。该婴儿随后接受了胰腺切除术。在早产儿中使用生长抑素类似物是安全的，但对该药物的耐受性会迅速发展。
相似文献
1
Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.
Arch Dis Child. 1991 Mar;66(3):341-3. doi: 10.1136/adc.66.3.341.
2
Somatostatin analogue SMS 201-995 in the short-term management of neonatal hyperinsulinism due to nesidioblastosis.
Aust Paediatr J. 1988 Dec;24(6):375-8. doi: 10.1111/j.1440-1754.1988.tb01395.x.
3
Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
J Pediatr. 1990 May;116(5):747-50. doi: 10.1016/s0022-3476(05)82665-4.
4
The enigma of persistent hyperinsulinemic hypoglycemia of infancy.
J Pediatr. 1993 Oct;123(4):573-5. doi: 10.1016/s0022-3476(05)80952-7.
5
Somatostatin analogue in short term management of hyperinsulinism.
Arch Dis Child. 1988 Dec;63(12):1493-4. doi: 10.1136/adc.63.12.1493.
6
The effects of a somatostatin analogue on the metabolism of an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic hypoglycaemia.
Eur J Pediatr. 1991 Jul;150(9):634-7. doi: 10.1007/BF02072623.
7
Normal growth after administration of octreotide: report on a case of persistent hyperinsulinemic hypoglycemia of infancy treated by continuous subcutaneous injection of octreotide.
Endocr J. 1999 Mar;46 Suppl:S47-9. doi: 10.1507/endocrj.46.suppl_s47.
8
Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.
Eur J Pediatr. 2000 Jul;159(7):550. doi: 10.1007/s004310051335.
9
Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis.
Acta Paediatr Scand. 1988 May;77(3):467-70. doi: 10.1111/j.1651-2227.1988.tb10683.x.
10
Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy.
Digestion. 1990;45 Suppl 1:27-35. doi: 10.1159/000200258.
引用本文的文献
1
Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.
Ther Adv Endocrinol Metab. 2020 Dec 2;11:2042018820965068. doi: 10.1177/2042018820965068. eCollection 2020.
2
Growth and endocrine function after near total pancreatectomy for hyperinsulinaemic hypoglycaemia.
Arch Dis Child. 1996 May;74(5):379-85. doi: 10.1136/adc.74.5.379.
3
Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood.
Arch Dis Child. 1992 Feb;67(2):201-5. doi: 10.1136/adc.67.2.201.
本文引用的文献
1
Somatostatin treatment of insulin excess due to beta-cell adenoma in a neonate.
J Pediatr. 1980 Jan;96(1):145-51. doi: 10.1016/s0022-3476(80)80353-2.
2
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia.
Acta Paediatr Scand. 1981 Nov;70(6):889-95. doi: 10.1111/j.1651-2227.1981.tb06246.x.
3
Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis.
Acta Paediatr Scand. 1988 May;77(3):467-70. doi: 10.1111/j.1651-2227.1988.tb10683.x.
4
Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog.
J Pediatr. 1987 Oct;111(4):548-51. doi: 10.1016/s0022-3476(87)80118-x.
5
Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infant.
J Pediatr. 1985 May;106(5):792-4. doi: 10.1016/s0022-3476(85)80358-9.
6
Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin.
N Engl J Med. 1977 Jun 9;296(23):1323-6. doi: 10.1056/NEJM197706092962305.
Zotero 插件